<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4d67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font13" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font14" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font15" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font16" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font17" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="16" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="44" left="525" width="22" height="9" font="font1" id="p1_t2" reading_order_no="2" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="44" left="548" width="27" height="9" font="font3" id="p1_t3" reading_order_no="3" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/">Central</a></text>
<text top="756" left="508" width="46" height="10" font="font4" id="p1_t4" reading_order_no="69" segment_no="23" tag_type="text">Page 1 of 4</text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t5" reading_order_no="70" segment_no="24" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="35" left="55" width="259" height="23" font="font6" id="p1_t6" reading_order_no="0" segment_no="0" tag_type="title"><b>Immunity &amp; Ageing</b></text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="title"><a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="87" left="55" width="73" height="13" font="font8" id="p1_t8" reading_order_no="5" segment_no="3" tag_type="title">Commentary</text>
<text top="105" left="55" width="272" height="15" font="font9" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="title"><b>Immunosenescence and Vaccination</b></text>
<text top="122" left="55" width="117" height="14" font="font10" id="p1_t10" reading_order_no="7" segment_no="5" tag_type="text">Graham Pawelec*</text>
<text top="158" left="55" width="309" height="8" font="font11" id="p1_t11" reading_order_no="8" segment_no="6" tag_type="text">Address: Center for Medical Research (ZMF), University of Tubingen, Tubingen, Germany</text>
<text top="172" left="55" width="185" height="8" font="font11" id="p1_t12" reading_order_no="9" segment_no="7" tag_type="text">Email: Graham Pawelec* - Grahampawelec@aol.com</text>
<text top="184" left="55" width="92" height="8" font="font11" id="p1_t13" reading_order_no="10" segment_no="8" tag_type="text">* Corresponding author  <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16307681">  </a></text>
<text top="332" left="112" width="44" height="10" font="font12" id="p1_t14" reading_order_no="23" segment_no="16" tag_type="title"><b>Abstract</b></text>
<text top="347" left="112" width="386" height="9" font="font13" id="p1_t15" reading_order_no="24" segment_no="17" tag_type="text">The problems associated with the ageing immune system and vaccination were discussed recently</text>
<text top="358" left="112" width="386" height="9" font="font13" id="p1_t16" reading_order_no="25" segment_no="17" tag_type="text">at an international workshop at the Jenner Institute for Vaccine Research, Compton, UK, 6–7</text>
<text top="370" left="112" width="386" height="9" font="font13" id="p1_t17" reading_order_no="26" segment_no="17" tag_type="text">October, 2005. This is a commentary on that session. The meeting included discussions on T and</text>
<text top="382" left="112" width="386" height="9" font="font13" id="p1_t18" reading_order_no="27" segment_no="17" tag_type="text">B cell differentiation and ageing, as well as dendritic cell and neutrophil data, with the emphasis on</text>
<text top="394" left="112" width="385" height="9" font="font13" id="p1_t19" reading_order_no="28" segment_no="17" tag_type="text">T cell immunosenescence, perceived as the most important hindrance to satisfactory responses to</text>
<text top="405" left="112" width="386" height="9" font="font13" id="p1_t20" reading_order_no="29" segment_no="17" tag_type="text">vaccines in the elderly. The main questions to be addressed in this context are the reasons for</text>
<text top="417" left="112" width="386" height="9" font="font13" id="p1_t21" reading_order_no="30" segment_no="17" tag_type="text">dysfunctionality of T cells in the elderly and what to do to improve T cell function. Several of the</text>
<text top="429" left="112" width="386" height="9" font="font13" id="p1_t22" reading_order_no="31" segment_no="17" tag_type="text">major reasons for poor T cell responses in the elderly were discussed; however, many important</text>
<text top="441" left="112" width="386" height="9" font="font13" id="p1_t23" reading_order_no="32" segment_no="17" tag_type="text">questions remain: The next meeting at the Jenner Institute may already be able to provide some of</text>
<text top="452" left="112" width="386" height="9" font="font13" id="p1_t24" reading_order_no="33" segment_no="17" tag_type="text">the answers to these questions, which have serious implications for public health issues in</text>
<text top="464" left="112" width="125" height="9" font="font13" id="p1_t25" reading_order_no="34" segment_no="17" tag_type="text">increasingly elderly populations.</text>
<text top="514" left="55" width="63" height="10" font="font12" id="p1_t26" reading_order_no="35" segment_no="18" tag_type="title"><b>Introduction</b></text>
<text top="525" left="55" width="241" height="9" font="font14" id="p1_t27" reading_order_no="36" segment_no="20" tag_type="text">An international workshop on Immunosenescence and</text>
<text top="537" left="55" width="241" height="9" font="font14" id="p1_t28" reading_order_no="37" segment_no="20" tag_type="text">Vaccination was organised at the Jenner Institute for Vac-</text>
<text top="548" left="55" width="241" height="9" font="font14" id="p1_t29" reading_order_no="38" segment_no="20" tag_type="text">cine Research, Compton, UK, 6–7 October, 2005 by Peter</text>
<text top="560" left="55" width="241" height="9" font="font14" id="p1_t30" reading_order_no="39" segment_no="20" tag_type="text">Beverley (Jenner Institute), Arne Akbar (University Col-</text>
<text top="572" left="55" width="241" height="9" font="font14" id="p1_t31" reading_order_no="40" segment_no="20" tag_type="text">lege, London, UK) and Don Palmer (Royal Veterinary</text>
<text top="584" left="55" width="241" height="9" font="font14" id="p1_t32" reading_order_no="41" segment_no="20" tag_type="text">College, London, UK). The most profound clinical impact</text>
<text top="596" left="55" width="241" height="9" font="font14" id="p1_t33" reading_order_no="42" segment_no="20" tag_type="text">of age on the immune system concerns the response of the</text>
<text top="607" left="55" width="241" height="9" font="font14" id="p1_t34" reading_order_no="43" segment_no="20" tag_type="text">elderly to vaccination. The meeting included discussions</text>
<text top="619" left="55" width="241" height="9" font="font14" id="p1_t35" reading_order_no="44" segment_no="20" tag_type="text">on T and B cell differentiation and ageing, as well as den-</text>
<text top="631" left="55" width="241" height="9" font="font14" id="p1_t36" reading_order_no="45" segment_no="20" tag_type="text">dritic cell and neutrophil data, with the emphasis on T cell</text>
<text top="643" left="55" width="241" height="9" font="font14" id="p1_t37" reading_order_no="46" segment_no="20" tag_type="text">immunosenescence, perceived as the most important hin-</text>
<text top="654" left="55" width="241" height="9" font="font14" id="p1_t38" reading_order_no="47" segment_no="20" tag_type="text">drance to satisfactory responses to vaccines in the elderly.</text>
<text top="666" left="55" width="241" height="9" font="font14" id="p1_t39" reading_order_no="48" segment_no="20" tag_type="text">The main questions to be addressed in this context are the</text>
<text top="678" left="55" width="241" height="9" font="font14" id="p1_t40" reading_order_no="49" segment_no="20" tag_type="text">reasons for dysfunctionality of T cells in the elderly and</text>
<text top="689" left="55" width="160" height="9" font="font14" id="p1_t41" reading_order_no="50" segment_no="20" tag_type="text">what to do to improve T cell function.</text>
<text top="514" left="313" width="109" height="10" font="font12" id="p1_t42" reading_order_no="51" segment_no="19" tag_type="title"><b>What is the problem?</b></text>
<text top="525" left="313" width="241" height="9" font="font14" id="p1_t43" reading_order_no="52" segment_no="21" tag_type="text">Several of the major reasons for poor T cell responses in</text>
<text top="537" left="313" width="241" height="9" font="font14" id="p1_t44" reading_order_no="53" segment_no="21" tag_type="text">the elderly were discussed: is it a problem of stem cells</text>
<text top="548" left="313" width="241" height="9" font="font14" id="p1_t45" reading_order_no="54" segment_no="21" tag_type="text">with decreased potential for differentiation into naïve T</text>
<text top="560" left="313" width="241" height="9" font="font14" id="p1_t46" reading_order_no="55" segment_no="21" tag_type="text">cells? Is it a problem of the thymic environment not sup-</text>
<text top="572" left="313" width="241" height="9" font="font14" id="p1_t47" reading_order_no="56" segment_no="21" tag_type="text">porting this differentiation sufficiently any more? Is it a</text>
<text top="584" left="313" width="241" height="9" font="font14" id="p1_t48" reading_order_no="57" segment_no="21" tag_type="text">problem of naïve T cell ageing in the periphery and/or</text>
<text top="596" left="313" width="241" height="9" font="font14" id="p1_t49" reading_order_no="58" segment_no="21" tag_type="text">memory cell ageing and loss? The answers as they are</text>
<text top="607" left="313" width="241" height="9" font="font14" id="p1_t50" reading_order_no="59" segment_no="21" tag_type="text">emerging of course suggest that all these problems, and</text>
<text top="619" left="313" width="133" height="9" font="font14" id="p1_t51" reading_order_no="60" segment_no="21" tag_type="text">more, apply, as outlined below.</text>
<text top="643" left="313" width="241" height="9" font="font14" id="p1_t52" reading_order_no="61" segment_no="22" tag_type="text">Diana Wallace and Peter Beverley [<a href="">1</a>] at the Jenner Insti-</text>
<text top="654" left="313" width="241" height="9" font="font14" id="p1_t53" reading_order_no="62" segment_no="22" tag_type="text">tute, together with Derek Macallan in London, measured</text>
<text top="666" left="313" width="241" height="9" font="font14" id="p1_t54" reading_order_no="63" segment_no="22" tag_type="text">T cell turnover during human ageing by assessing the rate</text>
<text top="678" left="313" width="241" height="9" font="font14" id="p1_t55" reading_order_no="64" segment_no="22" tag_type="text">of uptake of deuterated glucose into DNA and its dilution</text>
<text top="689" left="313" width="241" height="9" font="font14" id="p1_t56" reading_order_no="65" segment_no="22" tag_type="text">with cell division. In healthy young people, CD45RO+</text>
<text top="701" left="313" width="241" height="9" font="font14" id="p1_t57" reading_order_no="66" segment_no="22" tag_type="text">cells divide more rapidly than CD45RA+ cells in both the</text>
<text top="713" left="313" width="241" height="9" font="font14" id="p1_t58" reading_order_no="67" segment_no="22" tag_type="text">CD4 and CD8 subsets, whereby CD45RO+ cells have a 26</text>
<text top="725" left="313" width="241" height="9" font="font14" id="p1_t59" reading_order_no="68" segment_no="22" tag_type="text">day half-life, with 2.7% of cells dividing every day,</text>
<text top="226" left="55" width="98" height="7" font="font15" id="p1_t60" reading_order_no="11" segment_no="9" tag_type="text">Published: 24 November 2005</text>
<text top="241" left="55" width="58" height="7" font="font16" id="p1_t61" reading_order_no="12" segment_no="12" tag_type="text"><i>Immunity &amp; Ageing</i></text>
<text top="241" left="113" width="22" height="7" font="font15" id="p1_t62" reading_order_no="13" segment_no="12" tag_type="text"> 2005, </text>
<text top="241" left="135" width="4" height="7" font="font17" id="p1_t63" reading_order_no="14" segment_no="12" tag_type="text"><b>2</b></text>
<text top="241" left="139" width="10" height="7" font="font15" id="p1_t64" reading_order_no="15" segment_no="12" tag_type="text">:16</text>
<text top="241" left="158" width="92" height="7" font="font15" id="p1_t65" reading_order_no="16" segment_no="12" tag_type="text">doi:10.1186/1742-4933-2-16</text>
<text top="226" left="310" width="97" height="7" font="font15" id="p1_t66" reading_order_no="21" segment_no="10" tag_type="text">Received: 02 November 2005</text>
<text top="236" left="310" width="98" height="7" font="font15" id="p1_t67" reading_order_no="22" segment_no="11" tag_type="text">Accepted: 24 November 2005</text>
<text top="255" left="55" width="248" height="7" font="font15" id="p1_t68" reading_order_no="17" segment_no="13" tag_type="text"><a href="http://www.immunityageing.com/content/2/1/16">This article is available from: http://www.immunityageing.com/content/2/1/16</a></text>
<text top="269" left="55" width="153" height="7" font="font15" id="p1_t69" reading_order_no="18" segment_no="14" tag_type="text">© 2005 Pawelec; licensee BioMed Central Ltd. </text>
<text top="279" left="55" width="492" height="7" font="font15" id="p1_t70" reading_order_no="19" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens<a href="http://creativecommons.org/licenses/by/2.0">e (http://creativecommons.org/licenses/by/2.0), </a></text>
<text top="288" left="55" width="400" height="7" font="font15" id="p1_t71" reading_order_no="20" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
